AksharChem India [AKSHARCHEM] vs Chemo-Pharma [CPL] Detailed Stock Comparison

AksharChem India Ltd.

NSE
Loading...

Chemo-Pharma Laboratories Inc.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: AksharChem India Ltd. wins in 7 metrics, Chemo-Pharma Laboratories Inc. wins in 11 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric AksharChem India Ltd. Chemo-Pharma Laboratories Inc. Better
P/E Ratio (TTM) 94.70 13.22 Chemo-Pharma Laboratories Inc.
Price-to-Book Ratio 0.59 2.69 AksharChem India Ltd.
Debt-to-Equity Ratio 28.44 48.02 AksharChem India Ltd.
PEG Ratio -0.19 0.42 Chemo-Pharma Laboratories Inc.
EV/EBITDA 14.04 13.60 Chemo-Pharma Laboratories Inc.
Profit Margin (TTM) -1.09% 6.53% Chemo-Pharma Laboratories Inc.
Operating Margin (TTM) -1.57% 11.52% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) N/A 11.52% N/A
Return on Equity 1.81% 20.97% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 1.15% 11.26% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $-93.80M $41.66M Chemo-Pharma Laboratories Inc.
Dividend Yield 0.20% N/A N/A
1-Year Return -17.00% -5.34% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 0.44 1.31 AksharChem India Ltd.
Enterprise Value $2.28B $5.40B Chemo-Pharma Laboratories Inc.
EV/Revenue Ratio 0.64 1.52 AksharChem India Ltd.
Gross Profit Margin (TTM) 42.92% 24.93% AksharChem India Ltd.
Revenue per Share (TTM) $445 $62 AksharChem India Ltd.
Earnings per Share (Diluted) $-4.82 $5.81 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.28 0.28 AksharChem India Ltd.

AksharChem India Ltd. vs Chemo-Pharma Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

AKSHARCHEM
CPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
AksharChem India Ltd.-0.54%-2.68%3.71%21.29%-17.19%-15.46%
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
AksharChem India Ltd.-17.00%-16.98%-42.43%-71.53%-71.53%-71.53%
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%

Performance & Financial Health Analysis: AksharChem India Ltd. vs Chemo-Pharma Laboratories Inc.

MetricAKSHARCHEMCPL
Market Information
Market Cap i₹1.56B₹4.62B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,29197,700
90 Day Avg. Volume i11,44668,661
Last Close₹205.87₹70.50
52 Week Range₹141.30 - ₹330.80₹52.67 - ₹87.75
% from 52W High-37.77%-19.66%
All-Time High₹945.00 (May 15, 2017)₹128.00 (Jan 06, 2025)
% from All-Time High-78.21%-44.92%
Growth Metrics
Quarterly Revenue Growth-0.11%0.40%
Quarterly Earnings Growth-0.11%0.41%
Financial Health
Profit Margin (TTM) i-0.01%0.07%
Operating Margin (TTM) i-0.02%0.12%
Return on Equity (TTM) i0.02%0.21%
Debt to Equity (MRQ) i28.4448.02
Cash & Liquidity
Book Value per Share (MRQ)₹325.51₹28.58
Cash per Share (MRQ)₹2.33₹0.05
Operating Cash Flow (TTM) i₹66.50M₹277.99M
Levered Free Cash Flow (TTM) i₹47.70M₹313.23M
Dividends
Last 12-Month Dividend Yield i0.20%N/A
Last 12-Month Dividend i₹0.50₹0.00

Valuation & Enterprise Metrics Analysis: AksharChem India Ltd. vs Chemo-Pharma Laboratories Inc.

MetricAKSHARCHEM (Apr 26, 2026)CPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i94.7013.22
Forward P/E iN/AN/A
PEG Ratio i-0.190.42
Price to Sales (TTM) i0.441.31
Price to Book (MRQ) i0.592.69
Market Capitalization
Market Capitalization i₹1.56B₹4.62B
Enterprise Value i₹2.28B₹5.40B
Enterprise Value Metrics
Enterprise to Revenue i0.641.52
Enterprise to EBITDA i14.0413.60
Risk & Other Metrics
Beta i0.280.28
Book Value per Share (MRQ) i₹325.51₹28.58

Financial Statements Comparison: AksharChem India Ltd. vs Chemo-Pharma Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAKSHARCHEM (2025)CPL (2025)
Revenue/Sales i3.46B2.85B
Cost of Goods Sold i2.08B2.07B
COGS % of Revenue i60.1%72.6%
Gross Profit i1.38B778.98M
Gross Margin i39.9%27.4%
Research & Development iN/AN/A
Operating Income (EBIT) i108.32M300.69M
Operating Margin i3.1%10.6%
EBITDA i244.08M353.29M
EBITDA Margin i7.0%12.4%
Pre-Tax Income i58.26M392.47M
Pre-Tax Income % of Revenue i1.7%13.8%
Income Tax i10.56M79.24M
Income Tax % of Revenue i0.3%2.8%
Net Income (Profit) i47.70M313.23M
Profit Margin i1.4%11.0%

Balance Sheet & Liquidity Metrics

MetricAKSHARCHEM (2025)CPL (2025)
Cash & Equivalents i1.44M12.05M
Total Current Assets i1.34B2.51B
Total Current Assets % of Revenue i38.8%88.1%
Total Current Liabilities i1.15B1.17B
Total Current Liabilities % of Revenue i33.3%41.2%
Long-Term Debt i133.16M109.50M
Long-Term Debt % of Revenue i3.8%3.8%
Total Shareholders Equity i2.64B1.49B
Retained Earnings i1.70B1.08B
Retained Earnings % of Revenue i49.0%37.9%
Property, Plant & Equipment i2.31B48.61M

Cash Flow Statement Comparison

MetricAKSHARCHEM (2025)CPL (2025)
Operating Cash Flow i66.50M277.99M
Operating Cash Flow % of Revenue i1.9%9.8%
Capital Expenditures i-442.03M-47.82M
Free Cash Flow i-93.80M41.66M
FCF Margin i-2.7%1.5%
Debt Repayment iN/A-359.80M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAKSHARCHEMCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.03M60.18M
Float Shares i2.30M17.41M
% Held by Insiders i71.19%69.98%
% Held by Institutions i0.00%0.00%
% Held by Public i28.81%30.02%

Dividend Analysis & Yield Comparison: AksharChem India Ltd. vs Chemo-Pharma Laboratories Inc.

MetricAKSHARCHEMCPL
Last 12-Month Dividend i₹0.50₹0.00
Last 12-Month Dividend Yield i0.20%N/A
3-Year Avg Annual Dividend i₹0.50₹0.00
3-Year Avg Dividend Yield i0.15%N/A
3-Year Total Dividends i₹1.50₹0.00
Ex-Dividend DateSep 23, 2024N/A